A detailed history of Legato Capital Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Legato Capital Management LLC holds 34,041 shares of CORT stock, worth $1.75 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
34,041
Previous 24,056 41.51%
Holding current value
$1.75 Million
Previous $781,000 101.54%
% of portfolio
0.21%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$29.51 - $46.26 $294,657 - $461,906
9,985 Added 41.51%
34,041 $1.57 Million
Q2 2024

Jul 26, 2024

BUY
$22.21 - $34.48 $192,782 - $299,286
8,680 Added 56.45%
24,056 $781,000
Q3 2023

Oct 12, 2023

SELL
$21.97 - $33.8 $134,566 - $207,024
-6,125 Reduced 28.49%
15,376 $418,000
Q4 2022

Feb 01, 2023

BUY
$19.95 - $29.96 $428,944 - $644,169
21,501 New
21,501 $436,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.51B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.